Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/6/2025

Treatment Options for Post-Anabolic Steroid Use in Males

Pathophysiology and Impact of Anabolic Steroid Use

  • Exogenous testosterone administration provides negative feedback to the hypothalamus and pituitary gland, inhibiting gonadotropin secretion and potentially causing oligospermia or azoospermia 1
  • Recovery of natural testosterone production after anabolic steroid cessation can be prolonged, taking months or rarely years without intervention 1

First-Line Treatment Options

  • hCG directly stimulates testicular Leydig cells to produce testosterone, bypassing the suppressed hypothalamic-pituitary axis 1, 2
  • The American Urological Association recommends hCG as the only FDA-approved agent among fertility-preserving options for males with testosterone deficiency 2

Alternative and Adjunctive Treatments

  • Aromatase inhibitors reduce conversion of testosterone to estradiol, thereby decreasing negative feedback on the hypothalamic-pituitary axis 2

Monitoring and Follow-up

  • Measure initial follow-up total testosterone level after an appropriate interval to ensure target levels are achieved 3
  • Continue monitoring testosterone levels every 6-12 months while on therapy 3
  • Assess for symptom improvement (energy, libido, mood) as well as biochemical parameters 3

Important Considerations and Cautions

  • Avoid prescribing exogenous testosterone therapy in men desiring future fertility, as it can further suppress the hypothalamic-pituitary-gonadal axis 1, 2
  • Commercially manufactured products should be prescribed rather than compounded formulations when possible 4
  • Alkylated oral testosterone should not be prescribed due to risk of liver toxicity 5
  • Treatment should be discontinued if target testosterone levels are achieved but symptoms do not improve after 3-6 months 3

Predictors of Treatment Response

  • Testicular size prior to treatment correlates with response to hCG therapy 1